Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Natalizumab therapy for moderate to severe Crohn disease in adolescents.
Hyams JS, Wilson DC, Thomas A, Heuschkel R, Mitton S, Mitchell B, Daniels R, Libonati MA, Zanker S, Kugathasan S; International Natalizumab CD305 Trial Group. Hyams JS, et al. Among authors: wilson dc. J Pediatr Gastroenterol Nutr. 2007 Feb;44(2):185-91. doi: 10.1097/01.mpg.0000252191.05170.e7. J Pediatr Gastroenterol Nutr. 2007. PMID: 17255829 Clinical Trial.
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease.
Wang K, Zhang H, Kugathasan S, Annese V, Bradfield JP, Russell RK, Sleiman PM, Imielinski M, Glessner J, Hou C, Wilson DC, Walters T, Kim C, Frackelton EC, Lionetti P, Barabino A, Van Limbergen J, Guthery S, Denson L, Piccoli D, Li M, Dubinsky M, Silverberg M, Griffiths A, Grant SF, Satsangi J, Baldassano R, Hakonarson H. Wang K, et al. Among authors: wilson dc. Am J Hum Genet. 2009 Mar;84(3):399-405. doi: 10.1016/j.ajhg.2009.01.026. Epub 2009 Feb 26. Am J Hum Genet. 2009. PMID: 19249008 Free PMC article.
Guidelines for the management of inflammatory bowel disease in children in the United Kingdom.
Sandhu BK, Fell JM, Beattie RM, Mitton SG, Wilson DC, Jenkins H; IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition. Sandhu BK, et al. Among authors: wilson dc. J Pediatr Gastroenterol Nutr. 2010 Feb;50 Suppl 1:S1-13. doi: 10.1097/MPG.0b013e3181c92c53. J Pediatr Gastroenterol Nutr. 2010. PMID: 20081543 No abstract available.
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.
Turner D, Travis SP, Griffiths AM, Ruemmele FM, Levine A, Benchimol EI, Dubinsky M, Alex G, Baldassano RN, Langer JC, Shamberger R, Hyams JS, Cucchiara S, Bousvaros A, Escher JC, Markowitz J, Wilson DC, van Assche G, Russell RK; European Crohn's and Colitis Organization; Porto IBD Working Group, European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Turner D, et al. Among authors: wilson dc. Am J Gastroenterol. 2011 Apr;106(4):574-88. doi: 10.1038/ajg.2010.481. Epub 2011 Jan 11. Am J Gastroenterol. 2011. PMID: 21224839 Review.
Surgical Management of Crohn Disease in Children: Guidelines From the Paediatric IBD Porto Group of ESPGHAN.
Amil-Dias J, Kolacek S, Turner D, Pærregaard A, Rintala R, Afzal NA, Karolewska-Bochenek K, Bronsky J, Chong S, Fell J, Hojsak I, Hugot JP, Koletzko S, Kumar D, Lazowska-Przeorek I, Lillehei C, Lionetti P, Martin-de-Carpi J, Pakarinen M, Ruemmele FM, Shaoul R, Spray C, Staiano A, Sugarman I, Wilson DC, Winter H, Kolho KL; IBD Working Group of ESPGHAN (IBD Porto Group). Amil-Dias J, et al. Among authors: wilson dc. J Pediatr Gastroenterol Nutr. 2017 May;64(5):818-835. doi: 10.1097/MPG.0000000000001562. J Pediatr Gastroenterol Nutr. 2017. PMID: 28267075
Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response.
Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM, Loganathan S, Torrente F, Morris MA, Charlton C, Croft NM, Rodrigues A, Furman M, Vadamalayan B, Jenkins H, Zamvar V, Mitton SG, Chong S, Cosgrove M, Akobeng A, Wilson DC, Russell RK. Merrick VM, et al. Among authors: wilson dc. J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):274-280. doi: 10.1097/MPG.0000000000001679. J Pediatr Gastroenterol Nutr. 2018. PMID: 29356768
Use of Infliximab Biosimilar Versus Originator in a Pediatric United Kingdom Inflammatory Bowel Disease Induction Cohort.
Chanchlani N, Mortier K, Williams LJ, Muhammed R, Auth MKH, Cosgrove M, Fagbemi A, Fell J, Chong S, Zamvar V, Hyer W, Bisset WM, Morris MA, Rodrigues A, Mitton SG, Bunn S, Beattie RM, Willmott A, Wilson DC, Russell RK. Chanchlani N, et al. Among authors: wilson dc. J Pediatr Gastroenterol Nutr. 2018 Oct;67(4):513-519. doi: 10.1097/MPG.0000000000002011. J Pediatr Gastroenterol Nutr. 2018. PMID: 29697550 Free article.
Switching From Originator to Biosimilar Infliximab in Paediatric Inflammatory Bowel Disease Is Feasible and Uneventful.
Gervais L, McLean LL, Wilson ML, Cameron C, Curtis L, Garrick V, Armstrong K, Tayler R, Henderson P, Hansen R, Chalmers I, Wilson DC, Russell RK. Gervais L, et al. Among authors: wilson ml, wilson dc. J Pediatr Gastroenterol Nutr. 2018 Dec;67(6):745-748. doi: 10.1097/MPG.0000000000002091. J Pediatr Gastroenterol Nutr. 2018. PMID: 29985877 Free article.
470 results